Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dive

Showing results (171-180 of 207) with videos related to

Pageof 21
Sort By:
Cell Death and Differentiation|February 16, 2013
Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune responseM H M Melis, K L Simpson, S J Dovedi, et al.
Journal of Cell Science|February 1, 1997
Role of acid/base homeostasis in the suppression of apoptosis in haemopoietic cells by v-Abl protein tyrosine kinaseQ Chen, R S Benson, A D Whetton, et al.
British Journal of Cancer|April 28, 2012
Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trialJ Cummings, M Zweifel, N Smith, et al.
Journal of Cell Science|March 1, 1996
Requirement of basement membrane for the suppression of programmed cell death in mammary epitheliumS Pullan, J Wilson, A Metcalfe, et al.
British Journal of Cancer|January 7, 2010
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancerC Dive, R A Smith, E Garner, et al.
Cytometry|July 1, 1995
Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cellsR S Chapman, C M Chresta, A A Herberg, et al.
The HUGO Journal|December 2, 2011
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumoursK L Aung, R E Board, G Ellison, et al.
Oncogene|December 15, 2000
Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiationA Pierce, E Spooncer, S Wooley, et al.
Cancer Research|July 15, 1993
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathwaysT C Fisher, A E Milner, C D Gregory, et al.
British Journal of Cancer|March 23, 2013
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patientsR Stovold, S L Meredith, J L Bryant, et al.
Pageof 21

Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
Cell Death and Differentiation|February 16, 2013
Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune responseM H M Melis, K L Simpson, S J Dovedi, et al.
Journal of Cell Science|February 1, 1997
Role of acid/base homeostasis in the suppression of apoptosis in haemopoietic cells by v-Abl protein tyrosine kinaseQ Chen, R S Benson, A D Whetton, et al.
British Journal of Cancer|April 28, 2012
Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trialJ Cummings, M Zweifel, N Smith, et al.
Journal of Cell Science|March 1, 1996
Requirement of basement membrane for the suppression of programmed cell death in mammary epitheliumS Pullan, J Wilson, A Metcalfe, et al.
British Journal of Cancer|January 7, 2010
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancerC Dive, R A Smith, E Garner, et al.
Cytometry|July 1, 1995
Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cellsR S Chapman, C M Chresta, A A Herberg, et al.
The HUGO Journal|December 2, 2011
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumoursK L Aung, R E Board, G Ellison, et al.
Oncogene|December 15, 2000
Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiationA Pierce, E Spooncer, S Wooley, et al.
Cancer Research|July 15, 1993
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathwaysT C Fisher, A E Milner, C D Gregory, et al.
British Journal of Cancer|March 23, 2013
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patientsR Stovold, S L Meredith, J L Bryant, et al.
Pageof 21